Skip to content

Behavior Analytic Support of Needle-related Hospital Visits for Autistic Patients

Supporting Patients With Autism Spectrum Disorder (ASD) During Needle-related Hospital Visits Through the Use of Behavior Analytic Strategies

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06712784
Enrollment
10
Registered
2024-12-02
Start date
2026-07-07
Completion date
2027-03-01
Last updated
2026-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism Spectrum Disorder

Keywords

Behavior analytic research, Needle-related healthcare visits, Simulation visits, Differential reinforcement of alternative behavior (DRA)

Brief summary

The purpose of this study is to evaluate the effectiveness of the behavior analytic intervention in reducing the number of challenging behaviors exhibited by patients with Autism Spectrum Disorder (ASD) while increasing compliance with needle-related simulations and procedures. A second purpose is to assess the social validity of this study as evidenced by patient and/or caregiver acceptability. The study wil take place at Boston Medical Center (BMC). A Single Subject Design (SSD) wil be utilized as it allows for detailed, individualized assessment of how interventions affect behavior over time in this type of behavior analytic research. By focusing on each participant as an individual and having each participant act as their own control, it demonstrates clear cause-and-effect relationships, showing how behavior changes with the introduction or withdrawal of an intervention. This method is flexible, enabling ongoing adjustments to treatments based on real-time data, making it particularly useful in personalized interventions and ensuring effectiveness for patients with unique needs such as those who would be eligible to enroll and participate in this study.

Interventions

BEHAVIORALTreatment Package (for both simulation and procedure sessions

Treatment Package for both simulation and procedure sessions will include visit priming (contingency specifying stimuli in the form of social stories and YouTube videos) and differential reinforcement of alternative behavior (DRA).

Sponsors

Boston Medical Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
3 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Caregivers of autistic patients who have been historically engaged in challenging behaviors during needle-related procedures at a Boston Medical Center (BMC) * Established BMC autistic patients (ages 3+) who have a history of engaging in challenging behaviors in the presence of needle-related medical stimuli. * BMC Medical Providers (i.e., phlebotomists, medical doctors, registered nurses, certified nursing assistants, registered dieticians, and medical assistants) who either: 1) order needle-related medical procedures for participants to be conducted during procedure visits and/or 2) are present to conduct the ordered procedure * English speaking participants

Exclusion criteria

* Patients who are unable to visit BMC a minimum of 2 times per month * No history of challenging behaviors in medical appointments involving the presentation of needle(s) * Patients and caregivers who do not speak English or are unable to utilize interpreter services to complete assessments and surveys

Design outcomes

Primary

MeasureTime frameDescription
Number of participants who have a decrease in challenging behaviors in the presence of medical stimuli (needles)Baseline, on average 4 monthsA challenging behavior is defined as one that is either harmful, disruptive, or difficult to manage as documented on an investigator-developed task list.
Number of task list steps completed in the absence of challenging behaviorsBaseline, on average 4 monthsThis will be assessed using the investigator-developed task list.

Countries

United States

Contacts

CONTACTJacqueline McKendry, MS BCBA LABA
jacqueline.mckendry@bmc.org617 414 3874
PRINCIPAL_INVESTIGATORJacqueline McKendry, MS BCBA LABA

Boston Medical Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 10, 2026